These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 2573294

  • 1. Maternally administered esmolol produces fetal beta-adrenergic blockade and hypoxemia in sheep.
    Eisenach JC, Castro MI.
    Anesthesiology; 1989 Nov; 71(5):718-22. PubMed ID: 2573294
    [Abstract] [Full Text] [Related]

  • 2. Transplacental passage and hemodynamic effects of esmolol in the gravid ewe.
    Ostman PL, Chestnut DH, Robillard JE, Weiner CP, Hdez MJ.
    Anesthesiology; 1988 Nov; 69(5):738-41. PubMed ID: 2903702
    [Abstract] [Full Text] [Related]

  • 3. Maternally administered esmolol decreases fetal as well as maternal heart rate.
    Larson CP, Shuer LM, Cohen SE.
    J Clin Anesth; 1990 Nov; 2(6):427-9. PubMed ID: 1980197
    [Abstract] [Full Text] [Related]

  • 4. Maternal and fetal effects of labetalol in pregnant ewes.
    Eisenach JC, Mandell G, Dewan DM.
    Anesthesiology; 1991 Feb; 74(2):292-7. PubMed ID: 1671324
    [Abstract] [Full Text] [Related]

  • 5. Pharmacodynamics and onset of action of esmolol in anesthetized dogs.
    Quon CY, Gorczynski RJ.
    J Pharmacol Exp Ther; 1986 Jun; 237(3):912-8. PubMed ID: 2872328
    [Abstract] [Full Text] [Related]

  • 6. Ultra-short-acting beta-blockade: a comparison with conventional beta-blockade.
    Reilly CS, Wood M, Koshakji RP, Wood AJ.
    Clin Pharmacol Ther; 1985 Nov; 38(5):579-85. PubMed ID: 2865029
    [Abstract] [Full Text] [Related]

  • 7. Pulmonary reactivity to methacholine during beta-adrenergic blockade: propranolol versus esmolol.
    Tobias JD, Sauder RA, Hirshman CA.
    Anesthesiology; 1990 Jul; 73(1):132-6. PubMed ID: 1972872
    [Abstract] [Full Text] [Related]

  • 8. Hemodynamic effects of esmolol, an ultrashort-acting beta blocker.
    Askenazi J, MacCosbe PE, Hoff J, Turlapaty P, Hua TA, Laddu A.
    J Clin Pharmacol; 1987 Aug; 27(8):567-73. PubMed ID: 2888793
    [Abstract] [Full Text] [Related]

  • 9. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
    Angaran DM, Schultz NJ, Tschida VH.
    Clin Pharm; 1986 Apr; 5(4):288-303. PubMed ID: 2871961
    [Abstract] [Full Text] [Related]

  • 10. Defining the dose range for esmolol used in electroconvulsive therapy hemodynamic attenuation.
    Howie MB, Hiestand DC, Zvara DA, Kim PY, McSweeney TD, Coffman JA.
    Anesth Analg; 1992 Nov; 75(5):805-10. PubMed ID: 1358003
    [Abstract] [Full Text] [Related]

  • 11. Beta adrenergic stimulation and blockade in cirrhosis: effects on azygos vein blood flow and portal hemodynamics.
    Weinshel EH, Altszuler HM, Raicht RF, Sedlis SP.
    Am J Med Sci; 1994 Jun; 307(6):396-400. PubMed ID: 7911005
    [Abstract] [Full Text] [Related]

  • 12. Effect of esmolol on the ventricular fibrillation threshold.
    Wallis DE, Wedel VA, Scanlon PJ, Euler DE.
    Pharmacology; 1988 Jun; 36(1):9-15. PubMed ID: 2893394
    [Abstract] [Full Text] [Related]

  • 13. Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol.
    Sugiyama A, Takahara A, Hashimoto K.
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):70-7. PubMed ID: 10413070
    [Abstract] [Full Text] [Related]

  • 14. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol.
    Tempe DK, Mulchandani P, Tandon MS, Mehta N, Tomar AS, Banerjee A, Khanna SK.
    Indian Heart J; 1999 Jul; 51(3):294-300. PubMed ID: 10624069
    [Abstract] [Full Text] [Related]

  • 15. Esmolol: effects on isoprenaline- and exercise-induced cardiovascular stimulation in conscious dogs.
    Fischer G, Grohs JG, Raberger G.
    Can J Physiol Pharmacol; 1990 Oct; 68(10):1322-8. PubMed ID: 1981854
    [Abstract] [Full Text] [Related]

  • 16. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
    Mooss AN, Hilleman DE, Mohiuddin SM, Hunter CB.
    Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552
    [Abstract] [Full Text] [Related]

  • 17. Effect of nifedipine on fetal and maternal hemodynamics and blood gases in the pregnant ewe.
    Blea CW, Barnard JM, Magness RR, Phernetton TM, Hendricks SK.
    Am J Obstet Gynecol; 1997 Apr; 176(4):922-30. PubMed ID: 9125622
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular and antiarrhythmic effects of esmolol in children.
    Trippel DL, Wiest DB, Gillette PC.
    J Pediatr; 1991 Jul; 119(1 Pt 1):142-7. PubMed ID: 1676729
    [Abstract] [Full Text] [Related]

  • 19. Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy.
    Kirshenbaum JM, Kloner RF, McGowan N, Antman EM.
    J Am Coll Cardiol; 1988 Sep; 12(3):773-80. PubMed ID: 2900259
    [Abstract] [Full Text] [Related]

  • 20. Intrathecal clonidine in obstetrics: sheep studies.
    Eisenach JC, Dewan DM.
    Anesthesiology; 1990 Apr; 72(4):663-8. PubMed ID: 1969716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.